Call for Abstract
11th International Conference on Pharmacoepidemiology and Clinical Research, will be organized around the theme “Advanced Clinical research and compliance in Pharmacoepidemiologic studies.”
Pharmacoepidemiology congress is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Pharmacoepidemiology congress
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Pharmacoepidemiology is a broad science involving uses and effects of drugs in larger domains of population. Pharmacoepidemiology is a bridging science spanning both pharmacology and epidemiology. Pharmacoepidemiology enhances the informative study on topics apparently related to Pharmacoepidemiology, Pharmacokinetics, Adverse drug reactions, Public health, Epidemiologic methods, Medication adherence and Drug safety. This topic serves as a unique forum dedicated to scientists to express their findings as research presentations on an array of Pharmacoepidemiology and Drug Safety. The aims of pharmacoepidemiology within the industry are essentially the same as those of pharmacovigilance regulatory agencies; that is to protect patients from unnecessary harm by identifying the adverse effects, elucidating pre-disposing factors, refuting false safety signals and quantifying risk in relation to benefit. Clinical research is a branch of health care science that enables the use of various medications, medical and clinical devices, equipments and medical products for diagnosis, and treatment regimens used for the treatment of human disorders and diseases.
- Track 1-1Randomised clinical trials
- Track 1-2Prospective and retrospective cohort studies
- Track 1-3Case control studies and Case reports
- Track 1-4Molecular Pharmacoepidemiology
- Track 1-5Clinical Operations
- Track 1-6Clinical Research and Development
- Track 1-7Clinical Quality Assurance/Control
- Track 1-8Clinical Compliance
- Track 1-9Clinical and therapeutic Drug Monitoring
- Track 1-10Clinical Drug Reactions and interventions
- Track 2-1General Clinical Pharmacology
- Track 2-2Pharmacological testing and Toxicology
- Track 2-3Advances In pharmacological research
- Track 2-4Clinical toxicology
- Track 2-5Clinical Oncology
- Track 2-6Diabetic Clinical trials
- Track 2-7Pediatrics clinical trials
- Track 2-8Clinical trials in HIV/AIDS
- Track 2-9Neuropharmacology
- Track 2-10Psychopharmacology
Preclinical trials involves the assessment of potential therapeutic interventions in cells and animals. Clinical trials are the distinct procedures followed in development of new drugs. Clinical trials are the characteristic studies intended for the treatment of behavioral symptoms between a medical intervention and a health outcome. Clinical trials includes patient data, disease mechanisms, therapeutic interventions, epidemiology, clinical medicine, preclinical and clinical pharmacology, immunology, toxicological studies. Clinical trials involves experimental clinical trials comparing the new treatment replacing the placebo or existing alternative treatments and safety methodology using data from observation of patients treated in clinical.Clinical data is a key feature transforming basic research into medical care. The perfect outcome of clinical trials is minimize risks, extend benefits, and optimal use of an intervention of therapeutic drugs.
- Track 3-1Designing of trials: pre-clinical studies and different phases of clinical trials
- Track 3-2Bioassay and its types
- Track 3-3Data collection and quality control
- Track 3-4Alternative trials design and models
- Track 3-5Multi center trials and monitoring
A clinical trial is an experiment conducted on human subjects to test the medical treatments .The entire procedure of this theoretical science or formal study of clinical trials , planning and analysis of experiments, surveys, and observational studies is guided by statistical analysis. Statistical analysis in clinical trials help in establishing an objective framework for conducting an investigation by placing data and theory on an equal scientific footing and designing clinical data production through experimentation and quantifying the influence of chance and also to estimate the systematic and random effects.
- Track 4-1Drug discovery and drug screening
- Track 4-2Clinical research and Statistics
- Track 4-3ICH guidelines for clinical research and its statistics
- Track 4-4Data mining concepts and techniques
- Track 4-5Pharmacokinetics and Pharmacodynamics
- Track 4-6SAS Programing in Clinical Research and Pharmacutical Industry
- Track 4-7Global Clinical Innovations
Drug Safety is the pharmacological science ensuring safety and related to the collection, detection, assessment, monitoring, and prevention of adverse side effects with pharmaceutical products. Pharmacotherapy or drug therapy is using a medication to treat disease. Drugs interact with receptors or enzymes in cells to promote healthy functioning and reduce or cure illness. It is employed to treat a range of behavioural symptoms, disorders and diseases. Safety monitoring in clinical trials involves collecting adverse events, laboratory investigations including the planning, execution, data analysis and reporting of safety information and details of the clinical examination of patients.
- Track 5-1Drug Safety Regulations
- Track 5-2Drug Safety databases
- Track 5-3Drug Safety Training
- Track 5-4Drug Safety Surveilance
- Track 5-5Drug Safety Services & Softwares
- Track 5-6Drug Safety Reporting & Monitoring
- Track 6-1Biochemical pharmacology
- Track 6-2Ethanopharmacology
- Track 6-3Ocular pharmacology
- Track 6-4Cardiovascular Pharmacology
- Track 6-5Neuropharmacology
- Track 6-6Psychopharmacology
- Track 7-1Molecular Epidemiology
- Track 7-2Pharmacogenetics and Biomarkers
- Track 7-3Clinical Molecular Genetics
- Track 7-4Clinical Forensic Medicine
Pharma Risk Management was desgined as a set of pharmacovigilance activities and interventions designed to identify, characterise, prevent or minimise risks of medicinal and therapeutic products including the assessment of the effectiveness of their clinical reactions, interventions and combination therapies. Drug industry need to promote companies in pharmacovigilance practice to use information technology and provide efficient softwares to implement the risk minimisation plans in drug development and manufacture . Pharmaceutical risk management monitors unlicensed, off labels and orphan drugs ,risk management labeling, regulatory decisions, legal protection, intellectual property, enforcement, marketing, and company reputation.
- Track 8-1Information technology in pharmacoepidemiology and clinical trials
- Track 8-2Review of softwares used in pharmacovigilance and clinical trials
- Track 8-3Risk communication: Interface between pharmaepidemiology, sales and marketing
- Track 8-4Monitoring unlicensed, off labels and orphan drugs
- Track 8-5Implementation of Risk Minimization Plans
- Track 8-6Therapeutic drug Management
Adverse drug reactions is that unwanted harmful reaction or irritable side effect which is experienced after the administration of a drug or combination of drugs under normal conditions of use. Adverse drug reactions embrace rashes, jaundice, anemia, a decrease in the white white blood cell count, kidney damage, and nerve injury that will impair vision or hearing. Affected people is also allergic or supersensitized to the drug owing to genetic variations in the way their body metabolizes or responds to medicine.
- Track 9-1Classification of various adverse drug reactions
- Track 9-2Mechanism of adverse drug reactions
- Track 9-3Assessing and reporting adverse drug reactions
- Track 9-4Expected and un-expected drug reactions and its reporting
A case report is a detailed report of the signs or symptoms of a disease or diagnosis, treatment, and follow-up of an individual patient upon treatment by a pharmaceutical product. It contains a profile of the patient. Case reports can play a relevant role in medical education and provide a structure for case-based learning. Case reports may be on unexpected association between diseases, disorders or unwanted symptoms. An unexpected event in the course of observing, treating a patient, possibilities of pathogenesis of a disease or an adverse effect.
- Track 10-1Cancer case reports
- Track 10-2Cardiovascular trials case report
- Track 10-3Case studies on sexually transmitted diseases
- Track 10-4Case studies on type 1 and type 2 diabetes
- Track 10-5Individual case safety reports
- Track 10-6Clinical Informatics
Pharmacovigilance plays a key role in all phases of clinical trials, including the planning, execution, data analysis and reporting of safety information and also bears an important responsibility for the expedited reporting of individual cases and safety updates required for regulatory authorities. The concept of Pharmacovigilance and its Significance enhances the impact of healthcare management on patient welfare and public health. Pharmacovigilance legislation gives an outlook on the rules and regulations to follow in Pharmacovigilance practice. The Role of pharma industries in the improvement of pharmacovigilance system is very crucial to maintain the safety data, detection and evaluation of drug safety signals through manual and medical devices reporting. Pharmacovigilance scope also deals as Ecopharmacovigilance (EPV), pharmacoenvironmentology and pharmacovigilance in herbal medicines. In addition, data from observational epidemiological studies are playing an increasingly important role.
- Track 11-1Pharmacovigilance and healthcare system
- Track 11-2Pharmacovigilance legislation
- Track 11-3Role of pharma industries in the improvement of pharmacovigilance system
- Track 11-4Detection and evaluation of drug safety signals through manual and medical devices reporting
- Track 11-5Ecopharmacovigilance (EPV), pharmacoenvironmentology and pharmacovigilance in herbal medicines
- Track 11-6Methods of pharmacovigilance
- Track 11-7Pharmacogenetic tests as tools in pharmacovigilance
Databases contain professional assessment of the potential of drugs and permits the risk- profit analysis of medicinal products taking under consideration new and emerging information, within the context of additive data. These database offers programming of alerts for fast cases, follow-up cases and reports submission to fulfill regulative timeline compliance. Data sources of pharmacoepidemiological databases are CPRD (Clinical Practice Research Datalink), IMS Health Disease Analyzer databases,PHARMO,Vigibase and Eudravigilance. Pharmacoepidemiology research studies may involve either data collected prospectively for the purpose of the particular study i.e. primary data, or data that were already collected for another purpose – as part of administrative records or patient health care , which is called secondary data.
- Track 12-1PE data Sources
- Track 12-2GlobaL Drug Surveillance
- Track 12-3Case Control Surveillance
- Track 12-4Prescription event Monitoring
- Track 12-5Automated databases
Regulatory affairs is developed to protect public health by controlling the safety and efficacy of medical devices and pharmaceutical drug products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics and complementary medicines. Regulatory affairs (RA), also called government affairs, is a profession within regulated industries, such as pharmaceuticals, medical devices, energy, banking, telecom etc.
- Track 13-1Pharmaceutical Research & Marketing
- Track 13-2Drug Application systems (INDA, NDA, SNDA, ANDA)
- Track 13-3Regulatory authorities’ guidelines harmonization
- Track 13-4Post Marketing Safety Surveillance
- Track 13-5Regulatory authorities and ethics committee
- Track 13-6USFDA, EU & MHRA
- Track 13-7Regulations in Pharmacovigilance
Clinical Pharmacy and Pharmacy Practice involves developing the professional roles of pharmacists and is the order of drug store which includes adding to the expert parts of drug specialists. It includes Disease-state management, Clinical drug interventions, Pharmacy professional development and pharmaceutical care, pharmaceutical compounding and health psychology, patient care, drug abuse prevention, prevention of drug interactions or minimisation of adverse events and drug incompatibility and community pharmacy.
- Track 14-1Pharmacy Practice and Patient compliance
- Track 14-2Good clinical Practices and Guidelines
- Track 14-3Disease State Management
- Track 14-4Patient Safety and Quality of Patient Care
- Track 14-5Drug Discovery and Evaluation
- Track 14-6Medical Practice and its challenges
The clinical trial industry is evolving in an ever growing pace with diversified and updated strategies in clinical research technologies and new clinical and experimental studies are being launched rapidly. Clinical trials play a prominent role in medicine development process, as they provide the best clinical data for the treatment of diseases and disorders. This track includes various research developments in the field of Herbal Medicines, dietary supplements and vetenary products.
- Track 15-1Epidemiology and Herbal Medicines and Dietary Supplements
- Track 15-2Epidemiology and vetenary products
- Track 15-3Pharmacovigilance of medical devices